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Sirs: Kleine-Levin syndrome (KLS)
is a rare recurrent hypersomnia as-
sociated with behavioural, cogni-
tive, eating and sexual disturbances
[1, 2]. A recent SPECT study in 7
patients with (KLS) showed de-
creased thalamic perfusion during
the hypersomnolent attacks [3].
These findings were later con-
firmed in a case report by Hong
et al. [4]. Proton magnetic reso-
nance spectroscopy (1H MRS) is a
noninvasive method of obtaining
metabolic information. By means
of MRS, different compounds can
be measured including N-acetylas-
partate (NAA), a marker of neu-
ronal integrity and glutamate-glut-
amine (Glu-Gln), which plays an
important role in excitatory neuro-
transmission and mitochondrial
metabolism [5].
We present a 19-year-old patient
with idiopathic, classical KLS. Over
a 4-year period he suffered 19
stereotypical hypersomnolent
episodes. The attacks were always
preceded or accompanied by fever
up to 39 °C, sore throat or stomach
pain. At the beginning of the
episodes mood depression was ob-
served, the patient was melan-
cholic, sad and withdrew socially.
Sleep behaviour reached 20
hours/day, interrupted by compul-
sive eating, 7–8/days without any
specific food preference resulting
in a weight gain of approximately 5
kg/attack. Sexual disinhibition with
masturbation, irritability, aggres-
siveness, cognitive and concentra-
tion disturbances were frequent.
The attacks usually ended with in-
somnia lasting 2–3 days and a sub-
sequent gradual improvement of
emotional state and cognition. The
patient described this phase as
awakening from a dream and had
difficulty recalling the events that
had occurred during the attack. In
the first year before treatment 12
attacks were observed. Under ther-
apy with lithium 30 mg/day and
valproic acid 2000 mg/day a re-
markable reduction in frequency
and severity of the episodes (7 at-
tacks over a period of 2.5 years)
was noted. The duration of the hy-
persomnolent episodes remained
unchanged, 10 days on average.
Hypocretin-1 in the cere-
brospinal fluid during an attack
was in the normal range, 530 pg/
ml.
The patient underwent 1H MRS
in an asymptomatic period and a
month later during a typical
episode. Because of presumed hy-
pothalamic [6] or thalamic [3, 4]
dysfunction in KLS we chose three
regions of interest: hypothalamus
and both thalami. MRS was per-
formed on a Philips Achieva 3.0 T
scanner. Single-voxel proton MR
spectra, voxels of 17 x 14 x 15 mm
in both thalami (3.57 cm3) and of
10  10  10 mm (1 cm3) in the hy-
pothalamus, were acquired and
processed to determine metabolite
concentration ratios. A remarkable
change between the two examina-
tions was observed in the concen-
tration ratios of NAA-NAAG, (total
NAA)/Cr and Glu-Gln/Cr (Fig. 1).
During the attack lower (total
NAA)/Cr ratios in the right
(–25.7 %) and left (–13.2 %) thal-
ami were observed. In the hypo-
thalamus the (total NAA)/Cr ratio
was slightly higher in the second
scan during the hypersomnolent
attack. The Glu-Gln/Cr ratio was
higher during the attack – in both
the right (59.8 %) and left (52.3 %)
thalamus. In hypothalamus a reli-
able value for Glu-Gln/Cr ratio was
obtained only during the second
scan and it was similar to the val-
ues in both thalami.
Different values for intraindi-
vidual metabolite ratio, variability
and reproducibility of the results
are reported in the literature, de-
pending on the technical parame-
ters of the acquisition and on the
region of interest. For example an
intraindividual temporal cortical
variation up to 12 % was observed
for (total NAA)/Cr and up to 29 %
for Glu-Gln/Cr on a 3T scanner [7].
The decrease in the (total NAA)/Cr
concentration ratio in both thalami
during the hypersomnolent
episode in our patient exceeds the
normal range of the intraindivid-
ual variability at 3T. Our finding
supports the hypothesis of a thala-
mic dysfunction in KLS, recently
suggested by other authors [3, 4].
This hypothesis is indirectly sup-
ported also by the observation of
KLS-similar symptoms (reduced
alertness, impaired sleep and be-
havioural changes) following para-
median thalamic strokes [8]. The
observed high Glu-Gln/Cr concen-
tration ratio in all regions of inter-
est during the episode points to ad-
ditional, global metabolic changes
in the brain. Glutamate is a pri-
mary excitatory neurotransmitter.
Decreased NAA/Cr and increased
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Glu + Gln/Cr ratios have been re-
ported in focal epilepsies in areas
without structural abnormalities,
linked to ictal and interictal epilep-
tiform activities [9] as well as in
the thalamus of patients with idio-
pathic generalised epilepsy, possi-
bly related to excitotoxicity [10].
The neuronal pathophysiology of
epilepsy is however different from
that of KLS. The remarkable in-
crease in Glu-Gln/Cr in our patient
may account for a depolarisation
block and post-excitatory suppres-
sion of various thalamic nuclei. A
consequence of the large cortical
projections of the thalamus may be
that it leads to a widespread corti-
cal suppression. As we report a sin-
gle case, a confirmation of our hy-
pothesis is needed.
■ Acknowledgments Dr. Pierluigi Pedrazzi,
Hospital “San Giovanni” Bellinzona who
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